These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 861116)

  • 1. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1977 May; 49(5):479-84. PubMed ID: 861116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of neostigmine on suxamethonium induced neuromuscular block in the dog.
    Cullen LK; Jones RS
    Res Vet Sci; 1980 Sep; 29(2):266-8. PubMed ID: 7466001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium.
    McCoy EP; Mirakhur RK
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):744-7. PubMed ID: 7484027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of suxamethonium blockade by neostigmine in patients with atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1975 Mar; 47(3):416-8. PubMed ID: 1138751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1975 Aug; 47(8):885-8. PubMed ID: 1201167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase.
    Bang U; Viby-Mogensen J; Wirén JE
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):600-4. PubMed ID: 2244450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-antagonism: a possible mechanism of tachyphylaxis in suxamethonium-induced neuromuscular block in man.
    Lee C
    Br J Anaesth; 1976 Nov; 48(11):1097-1102. PubMed ID: 999771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.
    Baraka A
    Anaesthesia; 1992 Mar; 47(3):217-9. PubMed ID: 1314525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of phase II succinylcholine block by neostigmine.
    Donati F; Bevan DR
    Anesth Analg; 1985 Aug; 64(8):773-6. PubMed ID: 4014742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.
    Ostergaard D; Viby-Mogensen J; Hanel HK; Skovgaard LT
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):502-7. PubMed ID: 1897345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does suxamethonium influence the subsequent dose requirements of alcuronium and its reversibility in children?
    Brown TC; Meretoja OA; Clare D; Bell B
    Anaesth Intensive Care; 1990 Nov; 18(4):479-82. PubMed ID: 2268013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurarisation following a suxamethonium-alcuronium sequence in patients with atypical cholinesterase.
    Baraka A; Sibai AN; Hamed M; Delleh R
    Anaesthesia; 1988 Apr; 43(4):310-1. PubMed ID: 3377154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients.
    Bang U; Viby-Mogensen J; Wirén JE; Skovgaard LT
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):596-9. PubMed ID: 2244449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed neuromuscular block. A re-assessment using train-of-four stimulation.
    Rouse JM; Bevan DR
    Anaesthesia; 1979; 34(7):608-13. PubMed ID: 229739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neostigmine antagonism of succinylcholine phase II block: a comparison with pancuronium.
    Futter ME; Donati F; Sadikot AS; Bevan DR
    Can Anaesth Soc J; 1983 Nov; 30(6):575-80. PubMed ID: 6315193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR; Kim YI; Sanders DB
    J Neurol Sci; 1983 Jun; 59(3):431-40. PubMed ID: 6875609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek.
    Jensen FS; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1992 Nov; 36(8):753-7. PubMed ID: 1334612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.